Fact CheckerSign in

NCT03091725Active, not recruiting

Postprandial Nutrient Homeostasis Before and After Weight Loss Induced by Low-calorie Diet or RYGB

Source: ClinicalTrials.gov · Last updated 25 Aug 2026

Brief summary (registry, in English)

The purpose of this study is to compare the metabolic responses to low-carbohydrate and standard-carbohydrate meals in African Americans and non-Hispanic White adults with obesity and the effect of weight loss induced by low-calorie diet (LCD) or Roux-en-Y gastric bypass (RYGB) on the metabolic responses to low-carbohydrate and standard meals. Participants will consume: 1) a standard-carbohydrate meal (\~49 g glucose) and 2) a low-carbohydrate (\~3.4 g glucose) meal on separate study visits performed in a randomized order. We will evaluate the meals' effect before and after \~16-18% weight loss on postprandial i) insulin kinetics, ii) glucose kinetics iii) β-cell function; iv) plasma triglyceride and non-esterified fatty acid concentrations; v) plasma hormone concentrations; vi) plasma cytokine concentrations; vi) plasma metabolomics; and vii) adipose tissue transcriptomics.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
13 Mar 2017
Start date
25 Apr 2017
Primary completion date
3 Jul 2025
Lead sponsor
Washington University School of Medicine
Diseases
Obesity
NCT number
NCT03091725

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 25 Apr 2017 to the primary completion date, 3 Jul 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous intestinal resection
  • Use of any medication that might, in the opinion of the investigator, affect metabolic function
  • Use or past use of hormone replacement therapy within the past 6 months

Other illness

  • Evidence of significant organ system dysfunction or disease other than obesity and T2D

Other

  • Regular use of tobacco products
  • Pregnant or breastfeeding
  • Exercise ≥90 minutes per week

Who the study is looking for

  • Surgery Group (RYGB):
  • Males and Females
  • Scheduled for RYGB surgery
  • Body Mass Index 35-60 kg/m²
  • Without Type 2 Diabetes (T2D)
    • LCD group:
  • Males and Females
  • Body Mass Index 35-60 kg/m²
  • Without Type 2 Diabetes (T2D)

Age in the registry: 25 years to 65 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beth Henk
Coordinator of this site? Confirm its status
St LouisUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.